STRIVE™ Awards Program

The PTC Therapeutics grant awards program Strategies to Realize Innovation, Vision, and Empowerment (STRIVE) recognizes and supports nonprofit organizations committed to serving rare disease communities. By recognizing the vital role patient advocacy groups play, we can give voice to those affected by these rare diseases.

Program Overview

The STRIVE Awards program was first launched in 2015 and occurs annually. It was designed to support programs that address unmet needs for the Duchenne community, to:

• Improve diagnosis and treatment of patients
• Improve quality of life for those living with Duchenne and their families
• Educate the public and healthcare professionals and raise Duchenne awareness
• Identify and foster the next generation of Duchenne patient advocates

There are two award categories for which groups can submit proposals: 

• Innovative: programs that help address the unmet needs of the rare disease community
  
• Transition to Adulthood: programs that support young people with Duchenne in their ‘transition to adulthood’

Application Process

The application window for the 2023 STRIVE Awards is now closed. Recipients will be announced on World Duchenne Awareness Day.